Skip to main content
SEER
NASDAQ Industrial Applications And Services

Seer Cuts 2026 Revenue Guidance to $13.5M-$14.5M on Q3 Revenue of $4.0M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.55
Mkt Cap
$89.149M
52W Low
$1.55
52W High
$2.375
52W Position info
0.0% above low
Off High info
35% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

SEER is trading near its 52-week low of $1.55 (0.0% above the low).

Summary

Seer reported Q3 revenue of $4.0M, down 3% year-over-year, and cut full-year 2026 revenue guidance to $13.5M-$14.5M from $16M-$18M. The company ended the quarter with $198.1M in cash and investments.


Key Events · Earnings and Guidance · SEER

  • Full-Year Guidance Cut Sharply

    2026 revenue guidance was lowered to $13.5M-$14.5M from $16M-$18M, with the company citing extended sales cycles from pressure on academic and government funding and late-stage opportunities closing later than planned.

  • Q3 Revenue Down 3% Year-Over-Year

    Revenue was $3.981M versus $4.121M a year earlier, but up from $3.1M in Q2 2026; gross profit was $1.879M at a 47% gross margin.

  • Losses Narrow on Cost Cuts

    Net loss was $13.738M, or $0.25 per share, versus $18.234M, or $0.32 per share, a year earlier, as operating expenses fell 23% to $16.5M.

  • Cash Position Supports Breakeven Plan

    Cash, cash equivalents and investments totaled $198.1M at September 30, 2026; the company says it has sufficient capital to reach cash flow breakeven.


Analysis · SEER · Industrial Applications And Services

Seer cut full-year 2026 revenue guidance to $13.5M-$14.5M from $16M-$18M, roughly a 15% reduction at the midpoint, as pressure on academic and government funding stretches sales cycles and late-stage deals slip. Q3 revenue of $4.0M was down 3% from a year ago, though it rose from $3.1M in Q2, and the net loss narrowed to $13.7M from $18.2M as operating expenses fell 23%. With $198.1M in cash and a stated path to cash flow breakeven, the balance sheet is not the issue; the growth story is. The update lands three weeks after the Special Committee rejected both buyout proposals and ended the M&A process, so the standalone plan now has to prove itself with a lower revenue base.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SEER was trading at $1.55 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $89.1M. The 52-week trading range was $1.55 to $2.38. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SEER - Latest Insights

SEER
Nov 10, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.54
Real-time Price: $1.61 info
Change: +$0.070 (+5%) info
Market Cap: $89.149M info
SEER
Nov 02, 2026, 2:08 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $1.74
Real-time Price: $1.61 info
Change: -$0.125 (-7%) info
Market Cap: $89.149M info
SEER
Nov 02, 2026, 8:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $1.64
Real-time Price: $1.61 info
Change: -$0.030 (-2%) info
Market Cap: $89.149M info
SEER
Oct 29, 2026, 4:30 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.75
Real-time Price: $1.61 info
Change: -$0.1423 (-8%) info
Market Cap: $89.149M info
SEER
Sep 18, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.86
Real-time Price: $1.61 info
Change: -$0.250 (-13%) info
Market Cap: $89.149M info